Filtered By:
Vaccination: Vaccines
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 39664 results found since Jan 2013.
South Africa: Aspen's Covid Vaccine Facility in Gqeberha Switches to Making Insulin for Africa
[Daily Maverick] Aspen South Africa will soon deliver millions of vials of human insulin to patients in Africa at a low cost after reaching an agreement with Novo Nordisk.
Source: AllAfrica News: Health and Medicine - September 21, 2023 Category: African Health Tags: Coronavirus Health and Medicine South Africa Southern Africa Source Type: news
Neonatal erythema multiforme associated with a rotavirus infection: A case report
CONCLUSION: The possibility of rotavirus, a major cause of pediatric gastrointestinal infections, being a trigger for neonatal EM should be considered.PMID:37727716 | PMC:PMC10506005 | DOI:10.12998/wjcc.v11.i24.5749
Source: Herpes - September 20, 2023 Category: Infectious Diseases Authors: Jung Jae Kim Joon Kee Lee Source Type: research
Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
DiscussionOur results call for a critical discussion regarding appropriate vaccination intervals and potential biomarkers for the prediction of (re)infection with SARS-CoV-2 in patients with MS receiving ocrelizumab.Unique identifierDRKS00029110; URL: http://apps.who.int/trialsearch/.
Source: Frontiers in Immunology - September 20, 2023 Category: Allergy & Immunology Source Type: research
Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant
In conclusion, nucleocapsid antibody provides instructive clues about the immunogenicity of nucleocapsid proteins by different seroconversion rates and titers according to the severity of infection, host immune status, and different variants of concern.PMID:37724496 | PMC:PMC10506902 | DOI:10.3346/jkms.2023.38.e292
Source: Journal of Korean Medical Science - September 19, 2023 Category: Biomedical Science Authors: Beomki Lee Jae-Hoon Ko Jin Yang Baek Haein Kim Kyungmin Huh Sun Young Cho Cheol-In Kang Doo Ryeon Chung Kyong Ran Peck Eun-Suk Kang Source Type: research
The Role of Artificial Intelligence in the Development of COVID ‑19 Vaccine
Dear Editor, The coronavirus disease ‑2019 (COVID‑19) pandemic is a phenomenon that has infected and killed many people in many countries. Vaccination has been suggested as a good way to fight COVID‑19, and it is certainly important to design a safe and effective vaccine. In the healthcare system, artificial intelligence (AI) is emerging as an effective tool. The use of AI in diagnosing various health conditions and interpreting complex medical issues is very significant. AI capabilities can be used as an effective tool to study SARS‑CoV‑2 and its capabilities, virulence, and genome. For example, machine learning...
Source: International Journal of Preventive Medicine - September 19, 2023 Category: International Medicine & Public Health Source Type: research
Nonclinical safety assessment of an mRNA Covid ‐19 vaccine candidate following repeated administrations and biodistribution
AbstractMessenger RNA (mRNA) vaccines have demonstrated efficacy against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in humans. mRNA technology holds tremendous potential for rapid control and prevention of emergencies due to its flexibility with respect to production, application, and design for an efficacious and safe use in humans. We assessed the toxicity and biodistribution of MRT5500, an mRNA vaccine encoding for the full-length of the SARS-CoV-2 spike protein and delivered by lipid nanoparticles (LNPs) containing a novel ionizable lipid, Lipid-1 in preclinical animal models. In the repeated dose tox...
Source: Journal of Applied Toxicology - September 19, 2023 Category: Toxicology Authors: Karine Broudic,
S ébastien Laurent,
Vladimir Perkov,
Charlene Simon,
Marie Garinot,
Nathalie Truchot,
Julie Latour,
Paul Désert Tags: RESEARCH ARTICLE Source Type: research
Non-infectious uveitis risk after Coronavirus Disease 2019 (COVID-19) vaccination: A nationwide retrospective cohort study
Since the onset of the global coronavirus disease 2019 (COVID-19) pandemic, a rapid surge in the number of cases during the initial outbreak precipitated the prompt development and distribution of vaccines for the general population. As of April 2023, 69.8% of the world's population has received at least one dose of a COVID-19 vaccine,1 and in the Republic of Korea, 87.6% of the population (approximately 44.8 million individuals) has received at least one dose.2
Source: American Journal of Ophthalmology - September 19, 2023 Category: Opthalmology Authors: Myung Soo Chang, Hae Rang Kim, Sunyeop Kim, Christopher Seungkyu Lee, Suk Ho Byeon, Sung Soo Kim, Seung Won Lee, Yong Joon Kim Tags: Original Articles Source Type: research
COVID-19 vaccine in hemodialysis patients: Time for a boost
CONCLUSION: The results show a dose-dependent association between IgG antibody levels and the number COVID-19 vaccines received. The study highlights the need for booster COVID-19 vaccination for patients on hemodialysis.PMID:37717958 | DOI:10.15537/smj.2023.44.9.20230285
Source: Saudi Medical Journal - September 17, 2023 Category: Middle East Health Authors: Waleed H Mahallawi Source Type: research
